跳轉至內容
Merck
全部照片(1)

Key Documents

437174

Sigma-Aldrich

反式-4-甲氧基肉桂酸异辛酯

98%, contains 500-1000 ppm BHT as stabilizer

同義詞:

2-Ethylhexyl trans -4-methoxycinnamate

登入查看組織和合約定價


About This Item

線性公式:
CH3OC6H4CH=CHCO2CH2CH(C2H5)(CH2)3CH3
CAS號碼:
分子量::
290.40
MDL號碼:
分類程式碼代碼:
12162002
PubChem物質ID:
NACRES:
NA.23

化驗

98%

形狀

liquid

包含

500-1000 ppm BHT as stabilizer

折射率

n20/D 1.545 (lit.)

bp

198-200 °C/3 mmHg (lit.)

密度

1.011 g/mL at 25 °C (lit.)

SMILES 字串

CCCCC(CC)COC(=O)\C=C\c1ccc(OC)cc1

InChI

1S/C18H26O3/c1-4-6-7-15(5-2)14-21-18(19)13-10-16-8-11-17(20-3)12-9-16/h8-13,15H,4-7,14H2,1-3H3/b13-10+

InChI 密鑰

YBGZDTIWKVFICR-JLHYYAGUSA-N

尋找類似的產品? 前往 產品比較指南

一般說明

2-Ethylhexyl trans-4-methoxycinnamate is a cinnamate ester which can be synthesized by using 4-methoxybenzaldehyde. It is majorly used as a UV filter/light absorber in the personal care products such as sunscreens.

象形圖

Environment

危險聲明

防範說明

危險分類

Aquatic Chronic 2

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 3

閃點(°F)

426.2 °F - closed cup

閃點(°C)

219 °C - closed cup

個人防護裝備

Eyeshields, Gloves, type ABEK (EN14387) respirator filter


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

The encapsulation effect of UV molecular absorbers into biocompatible lipid nanoparticles.
Lacatusu I, et al.
Nanoscale Research Letters, 6(1), 73-73 (2011)
Two-step semi-microscale preparation of a cinnamate ester sunscreen analog.
Stabile RG and Dicks AP
Journal of Chemical Education, 81(10), 1488-1488 (2004)
Energy efficiency for the removal of non-polar pollutants during ultraviolet irradiation, visible light photocatalysis and ozonation of a wastewater effluent.
Santiago-Morales J, et al.
Water Research, 47(15), 5546-5556 (2013)
Ann M Bode et al.
Cells, 9(7) (2020-07-16)
Solar ultraviolet (SUV) exposure is a major risk factor in the etiology of cutaneous squamous cell carcinoma (cSCC). People commonly use sunscreens to prevent SUV-induced skin damage and cancer. Nonetheless, the prevalence of cSCC continues to increase every year, suggesting
Timothy P Murphy et al.
Journal of the American College of Cardiology, 65(10), 999-1009 (2015-03-15)
Treatment for claudication that is due to aortoiliac peripheral artery disease (PAD) often relies on stent revascularization (ST). However, supervised exercise (SE) is known to provide comparable short-term (6-month) improvements in functional status and quality of life. Longer-term outcomes are

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務